Background & Sources: Reglan linked to Tardive Dyskinesia

An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.

Primary topic reference

Reglan linked to Tardive Dyskinesia — Background & Analysis — detailed background and analysis.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

World Health Organization (WHO)

Reference: World Health Organization (WHO)

Authoritative source for clinical, regulatory, and public-health background reading.